Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Prevention and control of meningococcal disease. Recommendations of the Advisory Committee on Immunization Practices (ACIP).

Literature DB >> 10902834

Prevention and control of meningococcal disease. Recommendations of the Advisory Committee on Immunization Practices (ACIP).

Abstract

This report summarizes and updates an earlier published statement issued by the Advisory Committee on Immunization Practices concerning the control and prevention of meningococcal disease (MMWR 1997:46[No. RR-5]:1-21) and provides updated recommendations regarding the use of meningococcal vaccine.

Entities: Disease

Mesh：

Substances：

Year: 2000 PMID： 10902834

Source DB: PubMed Journal: MMWR Recomm Rep ISSN： 1057-5987

Keyword Cloud
Cited

24 in total

1. Immunogenicity and safety testing of a group B intranasal meningococcal native outer membrane vesicle vaccine.

Authors: Rohit K Katial; Brenda L Brandt; Ellen E Moran; Stephen Marks; Victor Agnello; Wendell D Zollinger
Journal: Infect Immun Date: 2002-02 Impact factor: 3.441

2. Meningococcal disease: oh no, not another childhood vaccine.

Authors: Erica Weir
Journal: CMAJ Date: 2002-04-16 Impact factor: 8.262

3. Gram-negative Diplococcal Respiratory Infections.

Authors: Nargis Naheed; Maqsood Alam; Larry I. Lutwick
Journal: Curr Infect Dis Rep Date: 2003-06 Impact factor: 3.725

Review 4. The role of economic evaluation in vaccine decision making: focus on meningococcal group C conjugate vaccine.

Authors: Robert Welte; Caroline L Trotter; W John Edmunds; Maarten J Postma; Philippe Beutels
Journal: Pharmacoeconomics Date: 2005 Impact factor: 4.981

5. 2007 Guideline for Isolation Precautions: Preventing Transmission of Infectious Agents in Health Care Settings.

Authors: Jane D Siegel; Emily Rhinehart; Marguerite Jackson; Linda Chiarello
Journal: Am J Infect Control Date: 2007-12 Impact factor: 2.918

6. Preparedness for infectious threats: public-private partnership to develop an affordable vaccine for an emergent threat: the trivalent Neisseria meningitidis ACW135 polysaccharide vaccine.

Authors: Christopher B Nelson; Maureen Birmingham; Alejandro Costa; Joelle Daviaud; William Perea; Marie-Paule Kieny; Daniel Tarantola
Journal: Am J Public Health Date: 2007-04-05 Impact factor: 9.308

Prevention and control of meningococcal disease. Recommendations of the Advisory Committee on Immunization Practices (ACIP).

1. Immunogenicity and safety testing of a group B intranasal meningococcal native outer membrane vesicle vaccine.

2. Meningococcal disease: oh no, not another childhood vaccine.

3. Gram-negative Diplococcal Respiratory Infections.

Review 4. The role of economic evaluation in vaccine decision making: focus on meningococcal group C conjugate vaccine.

5. 2007 Guideline for Isolation Precautions: Preventing Transmission of Infectious Agents in Health Care Settings.

6. Preparedness for infectious threats: public-private partnership to develop an affordable vaccine for an emergent threat: the trivalent Neisseria meningitidis ACW135 polysaccharide vaccine.

Review 7. Prospects for vaccine prevention of meningococcal infection.

8. Risk and prevention of meningococcal disease among education workers: A review.

9. Hajj-related Neisseria meningitidis serogroup w135 in Mauritius.

10. Mass vaccination campaign following community outbreak of meningococcal disease.